Integrative genomics and transcriptomics analysis of human embryonic and induced pluripotent stem cells by Laurila, Kirsti et al.
BioData Mining
Laurila et al. BioData Mining  (2014) 7:32 
DOI 10.1186/s13040-014-0032-2RESEARCH Open AccessIntegrative genomics and transcriptomics analysis
of human embryonic and induced pluripotent
stem cells
Kirsti Laurila1†, Reija Autio2,3*†, Lingjia Kong2,4, Elisa Närvä4, Samer Hussein5,6, Timo Otonkoski6,
Riitta Lahesmaa4 and Harri Lähdesmäki1,4* Correspondence: reija.autio@uta.fi
†Equal contributors
2Department of Signal Processing,
Tampere University of Technology,
Tampere, Finland
3School of Health Sciences,
University of Tampere, Tampere,
Finland
Full list of author information is
available at the end of the articleAbstract
Background: Human genomic variations, including single nucleotide polymorphisms
(SNPs) and copy number variations (CNVs), are associated with several phenotypic
traits varying from mild features to hereditary diseases. Several genome-wide studies
have reported genomic variants that correlate with gene expression levels in various
tissue and cell types.
Results: We studied human embryonic stem cells (hESCs) and human induced
pluripotent stem cells (hiPSCs) measuring the SNPs and CNVs with Affymetrix SNP 6
microarrays and expression values with Affymetrix Exon microarrays. We computed
the linear relationships between SNPs and expression levels of exons, transcripts and
genes, and the associations between gene CNVs and gene expression levels. Further,
for a few of the resulted genes, the expression value was associated with both CNVs
and SNPs. Our results revealed altogether 217 genes and 584 SNPs whose genomic
alterations affect the transcriptome in the same cells. We analyzed the enriched
pathways and gene ontologies within these groups of genes, and found out that the
terms related to alternative splicing and development were enriched.
Conclusions: Our results revealed that in the human pluripotent stem cells, the
expression values of several genes, transcripts and exons were affected due to the
genomic variation.
Keywords: hESC, hiPSC, Association analysis, SNP, CNV, Gene expression, Exon
expression, Transcript expressionBackground
After sequencing the human genome, numerous projects have focused on characteriz-
ing genomic alterations and associating them with the different diseases or functional
elements of the genome. For example, the focus of two such projects, HapMap project
[1] and 1000 genomes [2], is to identify the variants in the human genome. These vari-
ants are diverse and include e.g. single nucleotide polymorphisms (SNPs), insertions,
deletions and copy number variations (CNVs) that comprise together 0.1% of the gen-
ome [3]. Moreover, the variants cause different types of phenotypic traits varying from
mild properties such as eye color to severe hereditary diseases. These traits can be the
consequences of alterations that are directly changing the protein function, or they can© 2014 Laurila et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
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splicing or methylation. Indeed, recent studies have shown that alterations in SNPs are
of great importance as they can affect gene expression levels, alternative splicing, DNA
methylation and miRNA-mediated gene expression levels in different types of cells
[4-7]. Similarly, CNVs have been associated with changes in gene expression values in
various cell types [8-10].
Several genome-wide studies have reported differences in cis-acting genomic varia-
tions between individuals and populations, in different cell types [11-14], and SNPs
have also been associated with transcript isoform variation and alternative splicing
[13-15]. Further, it has been reported that intronic SNPs are associated with both exon
skipping events and complex traits, and that they are also predicted to result in protein
domain changes [16]. Moreover, the correlation between SNPs and alternative splicing
of exons is found to be the strongest at the exon-intron boundary, and the SNP closest
to the alternative splicing event is most likely the functional one [4].
Genetic variants have been found to affect chromatin accessibility and transcription
factor binding resulting in gene expression changes and phenotypic variation [17]. To
that end, eQTLs are often (50%) DNase I sensitivity quantitative trait loci (dsQTLs)
and majority of dsQTLs are located near genes [17]. Some of the cis-acting variations
are similar across various cell types, while most of them can be detected in only some
tissue and cell types [18]. These cell type specific variations differ between separate dif-
ferentiation stages as has been shown with the cells of the hemapoietic system, using
stem cells, progenitor cells, and differentiated cells of the myeloid and erythroid line-
ages [19]. On the other hand, when comparing human induced pluripotent stem cells
(hiPSCs) with cells with less potency during the differentiation process, several auto-
somal allele-specific gene expressions remained similar during the differentiation
process and were more dependent on genotypes than cell types even though more
genes were expressed in hiPSCs [20]. However, similar behavior could not be detected
in X chromosomal regions [20].
Despite the importance of the associations between the SNPs and other measure-
ments, they have not yet been studied in human pluripotent stem cells. As most associ-
ation studies are linking SNPs to a specific disease, there is no such known phenotype
with the stem cells. The SNP arrays have been used in several studies of pluripotent
stem cells and they have been mostly utilized for the copy number analysis [8,21-23].
By associating the SNPs to the gene expression levels we believe we can find new
insights to the behavior of the pluripotent stem cells. As stem cells hold promise for
the future medicine, the possible aberrations in the genome level with their associations
to the transcriptomics must be recognized before the cells can be safely used for
example in stem cell therapy [23].
In this study, we detected the effects of SNPs on expression values of both human
embryonic stem cells (hESCs) and hiPSCs that are derived from fibroblasts. Further, we
analyzed the associations between the gene copy numbers and gene expression values
in hiPSCs. Similar associations between CNVs and gene expressions in hESCs have
been reported earlier [8]. Previously, it has been shown that when different vari-
ants are associated with the gene expression levels, only a small part (<2%) of the SNPs
(associated with 84% of gene expression differences) and CNVs (associated with 18%)
overlap [24]. We studied the correlations between the SNPs and the expression levels of
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bers and gene expressions. Further, we performed downstream analyses of the resulting
cis-acting pairs and detected the overlapping expression changes associated with SNPs
and CNVs.
Methods
Data sets
The analyzed data set consists of nine hESC, eight hiPSC and three fibroblast cell lines.
The copy numbers and gene expression value alterations of the hESC samples (FES21,
FES22, FES29, FES61, FES75, H9 (s14), H7 (s14) P38, H7 (s6) P132, H7 (s6) P237) were
studied in [8] whereas the copy numbers of the hiPSC samples, reprogrammed from fi-
broblasts (FiPS1-14, FiPS2-10, FiPS2-13, FiPS3-12, FiPS5-3, FiPS5-7, FiPS6-3, FiPS6-12)
and their parent fibroblast samples (IMR90, MRC5, HFF) were explored in [21]. Each of
these 20 samples was hybridized to both Genome-Wide Human SNP 6.0 (Affymetrix) and
GeneChip Human Exon 1.0 ST arrays (Affymetrix). The data can be downloaded from
Gene Expression Omnibus (GEO) with series numbers GSE15097 (hESC data [8]) and
GSE26173 (hiPSC and fibroblast SNP 6.0 array data [21]). The hiPSC and fibroblast expres-
sion data (GSE42625) are previously unpublished. The data analysis workflow can be seen
in Figure 1.
Exon array hybridizations
For measuring the expression values of the hiPSC samples, the RNA was isolated using
RNeasy Kit (Qiagen) and DNase I (Qiagen) digestion was performed to eliminate DNA
from RNA samples. The concentration of the samples was measured with NanodropFigure 1 The samples were measured with SNP arrays and exon arrays. The associations are
computed between the gene copy numbers and gene expression values. Further, the effects of the SNP
changes on the transcriptomics data in the levels of genes, transcripts and exons with two intervals, long
and short, are studied. The gene, transcript, and exon expression values, measured with the exon array, are
illustrated in blue, while the CNV and SNP values obtained with the SNP 6.0 array are colored red. The
arrows indicate the used values in each of the association analyses. The analysis results five lists of associations;
1) gene CNV – gene expression, 2) SNP – gene expression, 3) SNP – transcript expression, 4) SNP – exon (short)
expression, and 5) SNP – exon (long) expression.
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with the Affymetrix GeneChip Human Exon 1.0 ST arrays. All the samples were hy-
bridized in the Finnish Microarray and Sequencing Centre (Turku, Finland) according
to manufacturer's protocol as described in [8] and [21].Effect of gene copy number on expression values
The CNVs of the genes were detected with Affymetrix Genotyping Console (3.0.2) util-
izing the Birdseed v2 algorithm and were analyzed against the 40 in house hybridized
HapMap samples (available in GSE15097) as reported in [21]. We used the regional
GC correction, and the variations with at least five markers and length 10 kb in hiPSCs
[21] and 50 kb in hESCs [8] were considered to have a CNV. All the variations were
linked to Ensembl genes (build 49, corresponds the genome version hg18). The gene
expression values of the exon array samples were computed with the aroma.affymetrix
[25] package of Bioconductor [26] in R [27]. The probe values were directly linked to
Ensembl genes (build 49) with the CDF files provided by aroma.affymetrix and prepro-
cessed with the RMA method [28]. We performed the integration analysis for all the
genes having a duplication or deletion in copy number in at least one sample. All the
gene values in each sample were labeled based on the copy number value as gain, nor-
mal or loss. In the integration analysis, for each gene we computed a weight value
wi ¼ mG1−mG0ð ÞstdG1þstdG0ð Þ where the mG1 is the mean expression value and stdG1 is the standard
deviation of the gene i in those samples where the gene i was detected to be gained, and
mG0 and stdG0 are the mean and standard deviation of the expression values of the gene
in those samples where the copy number of the gene has not altered [8,9,29-31]. The
weight value corresponds to the difference between the groups. The weight value is high
in cases where the distance between the mean values of the groups is large and the devi-
ations within the groups are small. Therefore, high weight value for duplication indicates
that gene expression is likely to be over expressed due to duplication. Similarly, we com-
puted the weight values for the genes with the loss in their CNV. We computed the
p-values for each weight value by 10000 permutations, by permuting the sample la-
bels based on the permutation events. Further, the p-values were adjusted with the
Benjamini-Hochberg method.Effect of SNPs on expression values
The analysis between the SNPs and expression values was performed using R [27] and
Bioconductor [26] packages and the study was run in three different groups: for hESCs,
hiPSCs and for all samples (hESCs, hiPSCs and fibroblasts) together. The analysis steps
and the numbers of analyzed events after each analysis step are described in Figure 2.
Exon array data were analyzed separately in the levels of exons, transcripts and genes
using custom CDF files, version 11 [32] linking the probes to Ensembl (build 49, corre-
sponds the genome version hg18) genes, transcripts and exons. Additionally, several
probes providing possibly unreliable information were filtered out before the actual cor-
relation analysis. In the first filtering step, probes with low expression were considered
to be background probes and thus filtered out. The limit for the background probes in
Human Exon 1.0 ST Array (26 445 gene / 45 439 transcript / 23 2376 exon probesets)
was separately defined for every G + C content using the antigenomic probes of the
SNP 6.0 
Array
• 906600 SNPs
Normalize
• SNPRMA normalization
Filter out
• probes with at least one confidence 
value < 0.9 and SNPs with less than 
25 % of genotypic variation
• 379255 SNPs left
Filter out
• SNPs in gained or lost regions
• 366138 SNPs left
Filter out
• Data from X and Y chromosomes 
Exon 1.0 ST 
Array
• 26445 genes / 45439 transcripts / 
232376 exon probesets
Filter out
• probes with low expression
• probes with danger of cross 
hybridization
Filter out
• probes that may contain a SNP 
according to dbSNP
• 22431  / 42147 / 177836  
probesets left
Filter out
• probesets with 1 or 2 probes
• 17742 / 38068 / 109004   
probesets left
Normalize
• Normalize data with RMA 
algortihm
Find pairs   (SNP - genes,  SNP - transcripts, SNP - exons) 
Fit linear model and determine correlations
Figure 2 The scheme of the SNP-expression analysis steps. The description of each step includes also
the numbers of the remaining gene/transcript/exon probesets after the filtering. The numbers for the SNP
array are for the data set with all the samples. In the analysis of a single group of cells (hESCs or hiPSCs) the
number of SNPs after the second filtering step is slightly lower due to the lack of the genotypic variation.
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the antigenomic probes, and for each genomic probe of the array the maximum probe
intensity across all the samples was compared with the limit to qualify the probe be-
tween the background and non-background probes [13]. In addition to the filtering of
the low intensity probes, the probes that could be cross-hybridized were filtered out
[33]. Moreover, since single nucleotide polymorphisms (SNPs) at probe sequences can
affect the intensities of probes [34-37], especially they can severely bias exon expression
estimates in individuals, not when using pooled samples [38], we filtered out the probes
whose sequences had an SNP (SNP locations were determined using dbSNP version
129 [39]). As some of the exons are small, this QC filtering can result in removing
some SNP-exon pairs, in which an SNP is located inside the exon and could contain a
real association signal. Nevertheless, this additional QC step mainly removes false posi-
tives. Finally, the probesets with only one or two probes were masked out to avoid the
unreliability of the expression values [32]. This filtering dramatically reduced the num-
ber of analyzed probesets. For example in the gene level analysis, the original 26 445
different probesets are reduced to 17 742 due to the filtering and in the exon level
analysis the effect is even larger when more than half of the probesets are filtered out
(Figure 2). After the filtering, the expression values were computed with the Robust
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package [41].
SNP 6.0 arrays were analyzed using the Bioconductor oligo package [42]. First, the
array data was normalized using the SNPRMA normalization and the genotypes for
each of the 906 600 SNPs of the array were determined with the Correct Robust Linear
Model with Maximum likelihood based distance (CRLMM) method [42]. Further, the
SNPs with less than 25% of genetic variation among the samples, were filtered out as
well as the probes with a confidence value smaller than 0.9 in at least one of the sam-
ples. Remarkably, the number of filtered SNPs varied between the analyzed groups
(hiPSCs, hESCs and all samples) as the proportion of the genetic variation differs in
them. In the cases where an SNP was filtered out from the analysis for the whole data
set (i.e. 20 samples) it was removed of the hiPSCs or hESCs groups also. Finally, we fil-
tered out the SNPs occurring in the regions reported to have copy number changes in
hESCs [8] and in hiPSCs [21]. Likewise, we excluded the SNPs within regions of the
gained chromosomes of the samples having a mosaic karyotype.
After the data preparation for the SNPs and expressions, the SNPs were linked to
exons, transcripts and genes. For the exons the linking was performed with two differ-
ent ways; the SNP was considered to be linked to the studied exon if the polymorphism
occurred 1) in the exon sequence or in the adjacent intron regions (short interval) or
2) in the whole gene area (long interval). An SNP located within the transcript region
was considered to be linked to a transcript, as well as to a gene if located within or
5000 bps up- or downstream of the gene region. The linear relationships were detected
with correlation analysis separately performed for each SNP - exon / transcript / gene
pair by fitting a linear model for data (homozygous genotypes had values 1 and 3 and
the heterozygous one had the value 2) by linear regression analysis with R's lm func-
tion. The correlation p-values were adjusted with Benjamini-Hochberg multiple testing
correction method.
For validation, we studied the overlap between our associations and associations
in rSNPBase [43]. We studied also the relation of the expression correlating SNPs
with transcription factors. Specifically, the possible binding of the key embryonic
stem cell transcription factors (NANOG, OCT4, SOX2, E2F4) to the SNP-regions
was explored. This was performed by searching the overlapping SNP locations and
the parts of the reported transcription factor binding sites (TFBSs) for the key stem
cell factors identified with chromatin immunoprecipitation microarray (ChIP-chip)
[44]. We further studied possible overlap between TFBSs and the SNPs by predict-
ing the transcription factor (TF) binding to the SNP regions. The prediction of TF
binding was computed using the TRANSFAC (Release 2010.2) [45] human binding
motif position weight matrices (PWMs) (altogether 618 models) with the pseudo-
count 0.005. The binding was scored for the sequences of both SNP alleles by slid-
ing the PWM over the flanking SNP sequence and computing the maximum
binding score using uniform background probabilities [46]. Only the sequences with
at least 80% of the maximum possible binding score on either of the alleles were
further studied by computing the absolute difference of the binding scores between
the alleles. We also studied if the genes, whose expressions were correlated with
SNPs, showed enrichments in different pathways, networks or annotations. These
analyses were performed with core analysis of Ingenuity Pathway Analysis (IPA) with
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Annotation, Visualization and Integrated Discovery system (DAVID) [47,48].Results and discussion
Copy number variation association with gene expression in hiPSCs
In the analysis of hiPSC samples, 139 genes were detected to have a gain and 359 genes
a loss within the gene area in at least one of the samples (Additional file 1: Table S1).
With adjusted p-value <0.05 we detected together 29 genes having significant associ-
ation between a gain in copy number and a high expression value, and 188 genes be-
tween a loss in copy number and a low expression value (Table 1, Figure 3, Additional
file 1: Table S1). For these resulting genes, the average logarithmic fold change between
the expression values of the copied and normal samples is 0.589 (fold change 1.50) and
the average logarithmic fold change between the expression values of the normal and
lost samples 0.568 (fold change 1.48). The results of a similar association analysis of
gene copy numbers and the expression values of hESCs were reported in [8]. The hESC
data included larger regions with copy number changes when compared to the hiPCSTable 1 Top genes with highest FC change between the average gene expression values
between the gained and normal and lost and normal samples
HGNC Gene Gene description Logarithmic
fold change
Number Adjusted
p-value
GSTT1 ENSG00000184674 Glutathione S-transferase theta-1 1.8701 1 <0.0139
KCNMA1 ENSG00000156113 Calcium-activated potassium channel 1.7972 1 <0.0139
RNFT1 ENSG00000189050 RING finger and transmembrane 1.0443 1 <0.0139
APPBP2 ENSG00000062725 Amyloid protein-binding protein 0.9715 1 <0.0139
SMCHD1 ENSG00000101596 Structural maintenance of chromosomes
exible hinge domain-containing protein 1
0.85418 1 <0.0139
NDC80 ENSG00000080986 Kinetochore protein NDC80 homolog 0.80433 1 <0.0139
HEATR6 ENSG00000068097 HEAT repeat-containing protein 0.77267 1 <0.0139
HLA-DRB5 ENSG00000198502 HLA class II histocompatibility antigen,
DRB5 beta chain precursor
0.72371 5 <0.0139
METTL4 ENSG00000101574 Methyltransferase-like protein 0.70292 1 <0.0139
PPM1D ENSG00000170836 Protein phosphatase 1D 0.6493 1 <0.0139
PDPN ENSG00000162493 Podoplanin precursor (Glycoprotein 36) -2.9885 1 <0.036
ALPL ENSG00000162551 Alkaline phosphatase, tissue nonspecific
isozyme precursor
-2.16 1 <0.036
NPPB ENSG00000120937 Natriuretic peptides B precursor -1.6065 1 <0.036
RCAN3 ENSG00000117602 Calcipressin-3 (Regulator of calcineurin 3) -1.2506 1 <0.036
DFFA ENSG00000160049 DNA fragmentation factor subunit alpha -1.1259 1 <0.036
TPRG1L ENSG00000158109 Tumor protein p63-regulated gene
1-like protein
-1.1232 1 <0.036
CDA ENSG00000158825 Cytidine deaminase -1.0503 1 <0.036
DDI2 ENSG00000197312 Protein DDI1 homolog 2 -1.045 1 <0.036
MAD2L2 ENSG00000116670 Mitotic spindle assembly checkpoint
protein MAD2B
-1.0315 1 <0.036
AOF2 ENSG00000004487 Lysine-specific histone demethylase 1 -1.018 1 <0.036
ATAD3B ENSG00000160072 ATPase family AAA -1.0031 1 <0.036
The p-values are computed for the weight value with the permutation test and adjusted with the Benjamini-Hochberg criteria.
Figure 3 Expression and copy number values of the genes having a copy number variation in at
least one of the hESC (on the left) and hiPSC samples (on the right) across all the samples in the
analysis. The copy numbers are labeled with green - loss, white - no change, red -gain. The expression
values are normalized row-wise, and thus the color of each gene indicates the value of the gene in respect
to the other samples, red denoting high expression and green low expression value.
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rameters were chosen separately for different data sets to optimize CNV detection.
Therefore, tighter cut-offs for calling CNVs in the copy number analysis were used for
the hESC samples. In the hESC samples altogether 6248 genes were detected to be
gained, of which 1866 genes had a significant association between the CNV and expres-
sion. Further, 220 genes in hESC samples were detected to have a loss at least in one
sample, of which 90 genes were significantly associated with the low expression value
[8] (Figure 3). Further, 32 of these genes were detected to have association with both
loss and low expression and gain and high expression value.
Based on our results, altogether 70 genes have a significant association between the
copy number and expression value in both hiPSC and hESC samples (Figure 4). There
is a clear difference in the number of genes whose copy number has altered in the
hiPSCs and hESCs. In the hESC data, the long passage H7 samples are included, in
which large parts of the chromosomes have been duplicated [8]. In the hiPSC samples
there are no such huge CNVs, which is further the reason for the smaller number of
detected genes. The largest variations in the hiPSC data are in chromosome 1 of the
sample FiPS3-12 and chromosome 9 in FiPS1-14 (Additional file 2: Figure S1).
Figure 4 Venn-diagram of the genes detected to have significant association between the copy
number and gene expression in hESCs and hiPSCs.
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gene is altered only in one sample. Especially the clear majority of the genes that are
detected to have an association between the loss and low expression are locating in
1p36 which is only lost in the sample FiPS3-12 (Additional file 1: Table S1, Additional
file 2: Figure S1). This deletion does not occur in the parental fibroblast sample. How-
ever, there are many genes whose copy numbers have altered in several samples, such
as SUMF1 (ENSG00000144455, Sulfatase-modifying factor 1 precursor) and CFHR1
(ENSG00000080910, Complement factor H related protein 1 precursor) that are lost in
the fibroblast sample HFF and in all the four hiPSC samples derived from HFF, and also
further significantly associated with the low expression value in hiPSCs. In addition,
genes TBC1D3F (ENSG00000189309, protein coding TBC1 domain family member 3B)
and TBC1D3C (ENSG00000205019) gained in the IMR fibroblast sample are copied
not only in the hiPSCs derived from IMR but also in hiPSCs derived from other
fibroblasts, and are further having a significant association between the gained copy
number and a high expression value in hiPSC samples. The gene HLA-DRB5,
(ENSG00000198502, HLA class II histocompatibility antigen) which is gained in the
fibroblast samples HFF and MRC5, is also gained in all the hiPSCs derived from HFF
and MRC5, and has further an association between the gain and the expression value.
Interestingly, the gene DEFB4 (ENSG00000171711, Beta-defensin 2 precursor) is gained
in three hiPSC samples and is significantly associated to a high expression value even
though the copy number in all fibroblast samples is normal. In addition, there are two
genes SLC30A6 (ENSG00000152683, protein coding Zinc transporter 6) and TUBA8
(ENSG00000183785, protein coding Tubulin alpha-8 chain) that are gained in all of the
fibroblast and hiPSC samples. In total, 4% of the genes detected with an association be-
tween the changed copy number and expression value had a copy number variation
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lost associations), while 96% of these associated genes had a normal copy number value
in fibroblasts. Interestingly, our analysis detected genes for which the CNV in their re-
gion is actually associating negatively with the expression value. For the gene CALB1,
the deletion in copy number data resulted with more than 1.5 fold higher gene expres-
sion value, as well as gains have decreased with 1.5 fold the expression for NLGN4Y,
TMPRSS11, NEBL, GPC6 and C10orf113 (Additional file 1: Table S1). However, these
negative correlations were not confirmed with good p-values.
Furthermore, the functionality of the genes with positive association between the
copy number and the expression value in the hiPSC samples was detected with the en-
richment analysis on gene ontologies and pathways. Regulation of RAS protein signal
transduction, organelle localization, macromolecule catabolism, as well as alternative
splicing, alcaloid, coenzyme and secondary metabolism terms are significantly enriched
(Additional file 3: Table S2).
SNP association with exon, transcript and gene expression in hiPSCs and hESC
We computed the correlations between SNP genotypes and a gene/transcript/exon ex-
pression value by fitting a linear regression model between the genotype and expression
values in hiPSCs, hESCs and combined group of hiPSCs, hESCs, and fibroblasts. As
previous studies have reported some problems in microarray measurements, for ex-
ample hybridization caused by SNPs in the probe areas, the cross hybridization of sam-
ples to several probes, and the uncertainty in the genotype determination [34-37], we
filtered out several SNPs and exon array probes to reduce the number of false detec-
tions from the association analysis. After the filtering, the number of fitted models var-
ied from 30 000 to almost 1.5 million in comparison types (gene/transcript/exon)
between the groups (hiPSCs, hESCs, all), (see Methods). We fitted a linear regression
model for each SNP-expression pair and estimated the significance of the models with
the adjusted p-values of the slope of the model. For each comparison, the numbers and
characteristics of the correlating pairs with adjusted p-value < 0.10 are listed at Table 2
(the full lists of correlating pairs in each comparison in Additional file 4: Table S3).
When comparing hiPSCs and hESCs separately, only a few or none of the correlating
pairs could be identified, whereas while fitting the model to the whole data set, numer-
ous correlating pairs were detected. We believe that this is due to the low number of
samples and a conservative multiple testing correction method. As a result, we detected
genes with a correlation between the SNP and expression value, such as PHLDB2
(ENSG00000144824, pleckstrin homology-like domain, family B, member 2), affected
by the genotypic variation in SNP_A-4263698 (dbSNP code rs698360, alleles C/T),
which has lower gene expression in the samples with the genotype CC than in the sam-
ples with the genotype TT while the heterozygous CT genotype is related to a medium
expression value of the gene (Figure 5A). Further, the SNP_A-8715816 (dbSNP code
rs10986468, alleles A/T) has an effect on the expression of the second exon of the
ARPC5L gene, within which it is also located (Figure 5B). While the other probesets of
this gene are measuring steady expressions of the exons of this gene, with the genotype
AA in SNP_A-8715816 the expression is clearly down-regulated.
Within the resulted SNPs correlating with expression values, often only two ge-
notypes existed among the samples. This indicates that heterozygosity in a single
Table 2 Results of different SNP correlation analyses
Expression
measurement
Area of SNPs Group Number of
significant
correlation
pairs/number
of all pairs
Number of
unique genes/
transcripts/
exons affected
Number of
unique genes
Number of
correlating SNPs
inside/outside
gene/transcript/
exon regions
Gene gene5000bp hiPSC 0/100363 - - -/-
Gene gene5000bp hESC 206/129416 56 56 190/16
Gene gene5000bp All 27/149986 20 20 22/5
Transcript Transcript hiPSC 5/197884 5 1 5/-
Transcript Transcript hESC 1/231846 1 1 1/-
Transcript Transcript All 22/296333 20 8 22/-
Exon Short hiPSC 0/75180 - - -/-
Exon Short hESC 0/95038 - - -/-
Exon Short All 53/113050 42 35 4/49
Exon Long hiPSC 0/821655 - - -/-
Exon Long hESC 0/955091 - - -/-
Exon Long All 651/1230955 342 159 4/647
Short SNP area means the area of the studied exon and adjacent introns, long area means the whole gene area.
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iants in genotypes were equally common among different cell types, and thus these find-
ings seem to be independent of the stem cell type. Further, as the fibroblasts were
included in this part of the analysis, the results indicate that differentiated cells can also
have similar effects. Based on our analysis of separate groups of hiPSC and hESC data,Figure 5 Examples of the genes having correlation between genotypes and expression values and
Venn-diagram of the results of the SNP-analysis. A) Linear regression between the SNP_A-2052714
genotypes and gene PCNXL2 (ENSG00000135749, pecanex-like 2) expression. The dashed line illustrates the
computed linear regression line. The expression data for each genotype is visualized using the boxplot
representation. B) The gene structure of ARPC5L (ENSG00000136950, actin related protein 2/3 complex,
subunit 5-like), the location of exon ENSE00001432409 expression correlating SNP SNP_A-8715816
(rs10986468) and the mean expressions of samples of each genotype. The normalized logarithmic expression
values (y-axis) and the exon with the genomic location (x-axis) are connected with light blue line. Some of the
exons are not represented in exon array and thus their expression values are not measured. C) Summary of the
genes in each SNP analysis. Venn-diagram illustrates the detected genes in the levels of genes, transcripts and
exons with two intervals.
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However, in our analysis the sample size in the individual cell types is small, and as at
least 25% of variation in an SNP is required, some of the interesting correlations might
have been filtered out. Nevertheless, our results indicate that the expression differences
in stem cells can be caused by SNPs and therefore they should be taken into account
when considering the differential expression and alternative splicing.
Most of the associations in the levels of genes, transcripts and exons, were detected
when all the samples were combined into one sample group (Table 2). Our study re-
vealed three SNPs having an effect on the expression values at all the levels of genes,
transcripts and exons (Figure 5C). Further as the datasets overlap, if the transcript
expression is affected, the effect can always be seen at the gene level too. The majority
of the effects in the exon levels do not occur at the gene levels, indicating potential
cases of exon skipping or other alternative splicing events. Our results showed also that
the affecting SNPs are located usually at the introns or at one of the other exons when
affecting the exon expression, and within the gene region (not in the up-/downstream
regions), when affecting the gene expression. Also, we did not detect any SNP enriched
locations. The locations of SNPs detected to be associated with the expression
values of genes, transcripts and exons are illustrated with POMO [49] in Additional
file 5: Figure S2.
In total we found 584 SNPs that were associated with the expression value. Of these
SNPs 438 (75%) have been reported in other eQTL studies and 458 (78%) of them were
involved in RNA binding protein mediated regulation based on the rSNPBase [50]. Fur-
ther, we overlapped the detected SNP – expression associations in the gene level to the
list of rSNP related genes in the rSNPBase, and found out that 88% of our SNP- gene
pairs and 95% of the SNP – transcript pairs were found also in rSNPBase. As expected,
almost all of our SNP – exon pairs were not detected in the rSNPBase because
rSNPBase had only associations in gene level, and most our exon level findings were
exon specific and did not correspond to whole gene association in our data either. Fur-
ther, when we compared the SNP locations with the stem cells key transcription factors
(TF) (NANOG, OCT4, SOX2, E2F4) binding regions according to the ChIP-chip mea-
surements [44], none of the SNPs are located in the binding sites. Next, we studied if
the SNPs could affect other TF binding sites by comparing the binding scores com-
puted according to TRANSFAC position weight matrices, and detected 29 unique tran-
scription factors with a large difference in the binding score (Additional file 6: Table S4).
Thus, this analysis suggests transcriptional regulators, which may have a causal role in
regulating these genes in stem cells.
The functional analysis using the protein information resource (PIR) [50] for the
exons, transcripts, and genes associating with an SNP genotype variation (SNP located
in gene region) showed enrichment for alternative splicing and splice variant terms.
Further, the Ingenuity Pathway Analysis (IPA, Ingenuity® Systems, www.ingenuity.com)
showed that in several networks our result genes are not the most strategic genes of
the network, but rather the targets of other network molecules instead (Additional file 6:
Table S5, Table S6). For example in the network "Cellular Development, Embryonic
Development, Organ Development", one third of affected molecules (ATXN1, C9orf3,
KCNJ3, NUAK1) are indirect targets of TGFB1. Similar effects could be seen in other
networks as well. In particular, several of these networks are related to the development,
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ment etc. (Additional file 6: Table S6). This is however understandable, as 85% of the
samples in the analysis are pluripotent stem cells.
Overlap between SNP and CNV association results
Further, we wanted to know if the associated expression pairs with SNPs are the same
ones as the expressions associated with CNVs. Therefore, we compared the genes in
each group and found that four genes could be found in both of the results, all
these genes are detected in hESC samples. Genes ARNTL2 (ENSG00000029153, aryl
hydrocarbon receptor nuclear translocator-like 2) and PPP1CC (ENSG00000186298,
protein phosphatase 1, catalytic subunit, gamma isozym) are both in gained regions
and genes CDS2 (ENSG00000101290, CDP-diacylglycerol synthase) and LRRN4
(ENSG00000125872, leucine rich repeat neuronal 4) are in loss regions. Thus for these
four genes, we cannot rule out the possibility that the gene expression differences might
be related actually to copy number variations, and not to the genotype. All the other as-
sociations occurred only either between SNPs and the expression value or between CNV
and expression value, which indicates that most likely they were not due to other gen-
omic variation. This small amount of overlapping genes in these analyses also confirms
the finding that the CNV and SNP associations with expression levels overlap only
slightly [24].
Conclusions
In this paper, we have analyzed human embryonic and induced pluripotent stem
cells with two different methods for finding associations between genomic varia-
tions i.e. SNPs and CNVs, and the transcriptomics data. The results revealed several asso-
ciations between gene copy numbers and the gene expression values, and also some
associations between the SNPs and exon, transcript and gene expression values. Several
copy number associations can be found in hiPSCs suggesting similar features with gen-
omic instability as has been described in hESCs [8]. In hiPSCs data, we detected altogether
217 genes, i.e. ~1% of all genes, of which copy number variation were associated with the
expression value. Further, after careful filtering the suspicious SNP probes, we had 366138
SNPs of which 584 (0.16%) were significantly associated with the expression value in at
least one of the analysis done for the hESCs, hiPSCs and combined group of samples.
When also transcript and exon results were studied in the gene level, we had together 721
associations between SNP and genes.
Some integrative analyses have already been performed where individual variation
has been linked to transcription factor binding [51,52] or to DNA methylation [53]. We
believe that these type of analyses need to be correlated with the functional parameters
of differentiated stem cells in order to understand how the genetic and epigenetic vari-
ability of pluripotent stem cells translates into the performance and safety of their dif-
ferentiated progeny. Although we report several such genotype-transcriptome effects
here and as earlier results have shown [22], further studies are needed to understand
the significance of such associations. Meanwhile the size of the sample groups in such
studies should be enlarged to detect the subgroups having certain association. Particu-
larly in cell therapy studies, it would be essential to have the detailed information of
such associations.
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Additional file 1: Table S1. The associations between the gene copy number and the gene expression values.
The sheet 1 includes the copy numbers and gene expression values of all the genes gained in the hiPSC samples.
The column Mean Label Gain is the mean of the logarithmic expression values of the gene in samples that have a
gain in the copy number, and Mean Label No Gain in samples that do not have a gain. The weight and p-values
are from the association test, and the adjusted p-value shows the adjusted p-value. The sheet 2 gives the same
information for the lost genes.
Additional file 2: Figure S1. Copy number changes of the hiPSC samples a) FiPS3-12 and b) FiPS1-14. The blue
regions represent gains and the red regions losses.
Additional file 3: Table S2. The results of the enrichment analysis of the genes that are associated between the
copy number and the gene expression value. Analysis was computed with the DAVID software and EASE score.
Additional file 4: Table S3. The results of the correlation analyses between the SNPs and the expressions levels.
The exons, transcripts and genes in hESCs, hiPSCs and in the combined group of hESCs, hiPSCs and fibroblasts are
correlated with SNPs and the relationships are validated using SNP-Gene associations of rSNPBase.
Additional file 5: Figure S2. Illustration of the locations of the SNPs detected to have association with expression
values. Associations found in hESCs are marked as green, in hiPSCs as blue and in the combined group of hESCs,
hiPSCs and fibroblasts as red. The outermost ring indicates the cytobands, and the other rings from outer to inner are
SNPs associated with genes, transcripts, exons with short interval and exons with long interval.
Additional file 6: Table S4. Changes in transcription factor binding scores. BSD = binding score difference, max
BS =maximum possible binding score, (h) = hESC, (l) = long interval for SNPs, (s) = short interval for SNPs. Table S5.
Top functions of IPA analysis in the SNP genotype correlated genes. Table S6. Top networks of IPA analysis in the
SNP genotype correlated genes. The genes that are associated with SNPs in the analysis are bolded.
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